Cost-Effectiveness of lbasvir/Grazoprevir Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus Genotype I Infection and Chronic Kidney Disease in the United States

首页> 外文期刊>AIDS & hepatitis digest >Cost-Effectiveness of lbasvir/Grazoprevir Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus Genotype I Infection and Chronic Kidney Disease in the United States

【24h】

Cost-Effectiveness of lbasvir/Grazoprevir Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus Genotype I Infection and Chronic Kidney Disease in the United States

机译：LBASVIR / Grazoprevir在治疗和治疗经验丰富的乙型肝炎病毒基因型患者中使用的成本效果 - 在美国感染和慢性肾病

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study suggests that use of elbas-vir/grazoprevir (EBR/GZR) has the potential to substantially reduce the incidence of liver- and CKD-related complications and mortality in treat-ment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease.

机译：None

著录项

来源
《AIDS & hepatitis digest》 |2017年第1期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naive Patients with Chronic Hepatitis B Virus Infection [J] . Lu Zhang, Lei-Ping Hu, Min Chang, 中华医学杂志（英文版） . 2017,第022期
2. Efficacy and Safety of Ombitasvir plus Paritaprevir,Ritonavir and Ribavirin in Non-cirrhotic Treatment-naive and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection [J] . Manar Ahmed, Azza E.Mansey, Engy A.Wahsh, 当代医学科学(英文) . 2021,第003期
3. C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE (CKD) [J] . Bruchfeld A., Roth D., Nelson D., Transplant international : . 2015,第Suppla2期

机译：C-SURFER：GRAZOPREVIR PLUS ELBASVIR在未治疗和治疗丰富的丙型肝炎病毒（HCV）基因1型感染和慢性肾脏病（CKD）患者中
4. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study [J] . Roth David, Nelson David R., Bruchfeld Annette, The Lancet . 2015,第10003期

机译：初治和有治疗经验的丙型肝炎病毒基因型1感染和4-5期慢性肾脏病患者的Grazoprevir联合elbasvir（C-SURFER研究）：3期联合研究
5. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study (vol 386, pg 1537, 2015) [J] . Roth D., Nelson D. R., Bruchfeld A. The Lancet . 2015,第10006期

机译：Grazoprevir和elbasvir在未经治疗和有治疗经验的C型肝炎病毒基因型1感染和4-5期慢性肾脏病患者中的应用（C-SURFER研究）：一项3期联合研究（第386卷，第1537页，2015年）
6. Genotype and Serotype Identification of Hepatitis B Virus in Chronic Hepatitis B Patients Treated with Telbivudine [C] . Y Purnamasari, Tien, Arimaswati, International Seminar on Smart Molecule of Natural Resources . 2020

机译：临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
7. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
8. Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France [O] . Franck Maunoury, Aurore Clément, Chizoba Nwankwo, -1

机译：Elbasvir-grazoprevir方案在法国治疗4-5岁慢性肾脏病患者的丙型肝炎病毒基因型1感染的成本效益分析
9. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study [O] . David Roth, David R Nelson, Annette Bruchfeld, 2015

机译：Grazoprevir加尔巴斯维尔在治疗 - 天真和治疗 - 经验丰富的丙型肝炎病毒基因型患者1感染和第4-5阶段慢性肾病（C-Surfer研究）：组合第3期研究
10. Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Similar Mass-Casualty Events-United States, 2008: Recommendations of the Centers for Disease Control (CDC). Morbidity and Mortality Weekly Report, Recommendation and Reports, Vol.57, No. RR-6 [R] . 2008

机译：关于暴露后干预以防止乙型肝炎病毒，丙型肝炎病毒或人类免疫缺陷病毒感染的建议，以及在爆炸和类似的大规模伤亡事件中受伤人员的破伤风 - 美国，2008年：疾病控制中心（CDC）的建议。发病率和死亡率每周报告，建议和报告，第57卷，第RR-6号

Cost-Effectiveness of lbasvir/Grazoprevir Use in Treatment-Naive and Treatment-Experienced Patients with Hepatitis C Virus Genotype I Infection and Chronic Kidney Disease in the United States

摘要

著录项

相似文献

相关主题

期刊订阅